Today's Veterinary Business

JUN 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link:

Contents of this Issue


Page 28 of 77

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2018 Zoetis Services LLC. All rights reserved. AIF-00577 1-888-ZOETIS1 • ® Reliability meets palatability in CLAVAMOX ® CHEWABLE (amoxicillin and clavulanate potassium tablets). Feature/Function: In a FDA-approved study CLAVAMOX CHEWABLE, featuring the same pork-liver-flavored base as RIMADYL ® (carprofen) Chewable had an overall voluntary acceptance rate of 83%. **,2 Benefit: CLAVAMOX CHEWABLE is a highly palatable medication that pets will love! Feature/Function: Easy-to-Administer Benefit: CLAVAMOX CHEWABLE provides relief to pet owners and your staff from the stress and anxiety of struggling to medicate pets. Additionally, it can help overcome compliance issues. Feature/Function: Same indications, strengths, dosing, and efficacy of original CLAVAMOX Tablets. Benefit: Helps improve the health of your patients and practice with the preferred veterinary antibioitc, 1, trusted for more than 30 years. 3 Feature/Function: CLAVAMOX CHEWABLE is available in 100-count boxes instead of 210-count boxes. Benefit: Smaller box size reduces inventory costs and losses associated with unused, expired tablets. Over 50 million satisfied patients. Plus Rudy. *Not actual size. **One hundred twelve (112) dogs with 1567 total tablet administrations successfully completed the study and were included in the data summary. Of the 1567 doses administered, CLAVAMOX CHEWABLE tablets were fully consumed within five minutes 82.51% of the time. Tablets were fully consumed within two minutes 81.17% of the time. The percent acceptance was consistent over 14 doses (seven days). For the first dose given, 93/112 dogs (83.04%) consumed the entire dose within two minutes. For the last (14th) dose, 89/111 dogs (80.18%) consumed the entire dose within two minutes, indicating that tablet acceptability continued over time without development of aversion to the tablet(s). 1. Zoetis Data on File, 2005-2015. 50 million CLAVAMOX Tablets estimated from units sold and dispensed at label dose. 2. Data on file, Study No. A163C-US-13-170, Zoetis Inc. 3. Kynetec (formerly Ipsos) Research, Zoetis Custom Multi-Brand Health Quantitative Research Report, Dec 2016. IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to CLAVAMOX. Do not use in animals with a history of allergic reactions to penicillins or cephalosporins. See Brief Summary of full Prescribing Information on page 25. 1

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - JUN 2018